Kuo et al. found that CAPE can reduce the secretion of vascular endothelial growth factor (VEGF) by inhibiting the ROS, PI3K and HIF-1α signaling pathways in human retinal pigment epithelial cells under hypoxic conditions, thereby inhibiting tumor growth and metastasis [7,8]. Here, VEGFA is linked to neoplasm.